Drug Profile
BAY 509062
Alternative Names: 17 beta HSD inhibitor - Bayer; 17 beta Hydroxysteroid Dehydrogenase inhibitor - Bayer; Estradiol 17 beta dehydrogenase inhibitor - BayerLatest Information Update: 11 Dec 2003
Price :
$50
*
At a glance
- Originator Bayer
- Class Osteoporosis therapies
- Mechanism of Action Estradiol dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Osteoporosis
Most Recent Events
- 11 Dec 2003 No development reported - Preclinical for Osteoporosis in Germany (unspecified route)
- 28 Sep 2001 BAY 509062 is available for licensing
- 30 Mar 2001 New profile